FDA approves record breaking 971 generic drugs in 2018
pharmafile | January 10, 2019 | News story | Manufacturing and Production | FDA, approval, generic drugs, generics, regulation
The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in October alone, it has emerged.
The year saw an improvement on the previous record of 937 generics approvals set in 2017. The cost saving medicines were said to have saved consumers as much as $26 billion between January 2017 and July 2018.
As said by FDA commissioner Scott Gottlieb “Over the past two consecutive years, the agency approved record numbers of generic drugs. Now we’re beginning the new fiscal year by breaking another record, this time with the highest number of approved or tentatively approved generics ever in a month.
Through our efforts, generic drugs entering the market from January 2017 through July 2018 saved consumers $26 billion through the lower prices they enabled.”
Louis Goss
Related Content
Roche’s Alecensa approved by FDA as lung cancer treatment
Roche has announced that the US Food and Drug Administration (FDA) has approved Alecensa (alectinib) …
GSK’s meningococcal vaccine candidate accepted for FDA review
GSK has announced that the US Food and Drug Administration (FDA) has accepted for review …
FDA grants ODD to Candel Therapeutics’ pancreatic cancer treatment
Candel Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Orphan …